Bionano Genomics, Inc. (BNGO) Net margin 2017–2025
Bionano Genomics, Inc. (BNGO) net profit margin by fiscal year — reported net income divided by reported revenue.
-92.6%FY2025 · since FY2017: -245.8% → -92.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -92.6% | +271.4 pp |
| FY2024 | -364.0% | +279.8 pp |
| FY2023 | -643.7% | -166.8 pp |
| FY2022 | -476.9% | -74.1 pp |
| FY2021 | -402.8% | +80.6 pp |
| FY2020 | -483.4% | -189.1 pp |
| FY2019 | -294.3% | -140.2 pp |
| FY2018 | -154.1% | +91.7 pp |
| FY2017 | -245.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BNGO financial trends
BNGO RevenueBNGO Net incomeBNGO Gross profitBNGO Gross marginBNGO Operating incomeBNGO Operating marginBNGO Operating cash flowBNGO Free cash flowBNGO Capital expendituresBNGO Return on equityBNGO Stock buybacksBNGO Dividends paidBNGO Total assetsBNGO Total liabilitiesBNGO Shareholders’ equityBNGO overview →